Moumita Maji

8PUBLICATIONS
14CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 15, 2026
A New Class of Multitargeting PtIV Anticancer Agents: Prodrugs That Release PtII Drugs and Bioactive Moieties Tethered to PtIV via a Tertiary Amine.

Moumita Maji, Michele De Franco, Sourav Acharya

|Nov 10, 2025
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Sofia Sharkawy, Sourav Acharya, Hana Kostrhunová

|Aug 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji

|Mar 24, 2021
Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p-Cymene Complexes.

Moumita Maji, Sourav Acharya, Indira Bhattacharya

|Mar 12, 2021
Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells.

Moumita Maji, Indira Bhattacharya, Sourav Acharya

|Feb 08, 2021
Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases.

Sourav Acharya, Moumita Maji, Manas Pratim Chakraborty

Pageof 2

Frequent Collaborators

6 joint publications

Sourav Acharya

5 joint publications

Arindam Mukherjee

3 joint publications

Dan Gibson

2 joint publications

Vojtech Novohradsky